A HO-1 gene knockout using a NanoCRISPR scaffold suppresses metastasis in mouse models
- 22 October 2025
- journal article
- research article
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 10 (6) , 1096-1112
Abstract
Photodynamic therapy-induced immunogenic cell death has the potential to generate autologous cancer vaccines. However, the innate or evolved genetic tolerance of tumours limits the efficacy of this approach. Here we report the development of a heritable nanoplatform based on gene editing of haem oxygenase-1 (HO-1) using a NanoCRISPR/HO-1 scaffold. This platform effectively eliminates genetic tolerance to reactive oxygen species in tumours without causing adverse effects on main immune cells, resulting in a robust and durable immune response to autologous vaccine. This NanoCRISPR scaffold can inherit susceptibility to tumour progeny, transforming heterogeneous malignancies into a reactive oxyen species-sensitive phenotype. Moreover, the arginine-grafted polyethyleneimine module and CpG motif within the NanoCRISPR scaffold enhance the cancer-immune cycle by amplifying antigen generation, promoting T cell proliferation and activating adaptive immune response in cancer models. When combined with an αPD-L1 antibody, the NanoCRISPR scaffold-based heritable nanoplatform elicits antitumour immunity and durable immunological memory in vivo melanoma mouse models. This combinational therapy evokes a strong immune memory against tumour rechallenge, providing insights into the rational development of a cancer vaccine regimen.Keywords
Funding Information
- National Natural Science Foundation of China (No. 32371451, 22205151 and 32201148)
This publication has 69 references indexed in Scilit:
- NIR‐Absorbing B,N‐Heteroarene as Photosensitizer for High‐Performance NIR‐to‐Blue Triplet‐Triplet Annihilation UpconversionAngewandte Chemie International Edition, 2023
- An Activity‐Based Photosensitizer to Reverse Hypoxia and Oxidative Resistance for Tumor Photodynamic EradicationAdvanced Materials, 2022
- Multifunctional light-activatable nanocomplex conducting temperate-heat photothermal therapy to avert excessive inflammation and trigger augmented immunotherapyBiomaterials, 2022
- Tumor Selective Metabolic Reprogramming as a Prospective PD‐L1 Depression Strategy to Reactivate ImmunotherapyAdvanced Materials, 2022
- Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapyAdvanced Drug Delivery Reviews, 2021
- Multistage Sensitive NanoCRISPR Enable Efficient Intracellular Disruption of Immune Checkpoints for Robust Innate and Adaptive Immune CoactivationAdvanced Functional Materials, 2020
- Light‐Triggered In Situ Gelation to Enable Robust Photodynamic‐Immunotherapy by Repeated StimulationsAdvanced Materials, 2019
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to NormalizationCell, 2018
- Rational Design of Cancer Nanomedicine: Nanoproperty Integration and SynchronizationAdvanced Materials, 2017
- Morphologically Virus‐Like Fullerenol Nanoparticles Act as the Dual‐Functional Nanoadjuvant for HIV‐1 VaccineAdvanced Materials, 2013